30th July 2019
PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, has announced the completion of its Series B funding having raised £10M.
25th July 2019
Keensight Capital, one of the leading private equity managers dedicated to pan-European Growth Buyout investments, announces the acquisition of Infarco’s majority stake in 3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in the process development and GMP manufacturing of biologics.
24th July 2019
Medical device company Flow, creators of the first and only medically approved treatment for depression of its kind in Europe, today announces it has raised $1.5m in an investment round led by Khosla Ventures to tackle the world’s most urgent mental health challenges. The investment will be used to support Flow’s European rollout, introduce Flow to healthcare clinics, and fund clinical studies.
23rd July 2019
Foresight Group has invested a further £4 million growth capital investment into portfolio company ONFAB to fund the acquisition of Lancashire based designer and manufacturer of clean air containment products, Envair Holdings Limited.
ONFAB produces flexible clean-air enclosures and consumables, designed and manufactured in-house from sites in Cheshire and Spain. Founded in 2005 by Oliver Nulty, ONFAB received investment from the £60 million Foresight Regional Investment LP fund in September 2017 to facilitate a majority buyout of the business. Since then, with an enlarged team and renewed focus on sales, margins and new products, it has grown by over 30% per year and continues to benefit from ever stricter safety standards protecting workers across the globe.
22nd July 2019
Asabys Partners, a Pan-European Venture Capital firm specialized in investments in the life sciences and health sectors, and Alantra, an investment banking and asset management firm, have reached an agreement by which Alantra becomes a strategic partner of Asabys through the acquisition of a 35% stake in the firm.
The transaction has the support of Banc Sabadell as one of the promoters of the project and anchor investor in Asabys’ first vehicle ("Sabadell Asabys Health Innovation Investments SCR SA"). As part of the agreement, Alantra will invest in the first vehicle of Asabys and will support the search for new investors and the internationalization of the project.
17th July 2019
Luminous Ventures has made a £1million investment in Optellum, developers of the world’s first AI clinical diagnosis support software for personalized early lung cancer diagnosis and treatment.
15th July 2019
Aergo, a company that has developed a responsive posture support system which empowers wheelchair users, ahas completed an equity funding round with the help of ClearlySo, Europe’s leading impact investment bank. The funding will go towards expanding the team and product manufacturing and piloting.
1st July 2019
, the specialist life sciences venture capital investor, has closed its VBC III fund securing EUR 120 million of equity commitments. This includes commitments of EUR 30 million from the European Investment Fund (EIF) and new and existing investors from Europe, the Americas and MENA. The fund is a validation of Vesalius’ proven approach to invest in later-stage European life sciences companies, providing capital to support their development. Vesalius Biocapital III has executed three investments to date.
1st July 2019
Foresight Group LLP has announced a £4 million growth capital investment into Ten Health and Fitness Limited, a fast-growing provider of health and fitness services in London.
25th June 2019
North West-focused Praetura Ventures has backed fertility startup Dr Fertility in a £1m seed round. The first investment of Praetura’s maiden EIS Fund will be used to develop Dr Fertility into a full-service digital health platform. Founded by Dr Lucy Buckley, PhD and Kobi McCardle in June 2018, Dr Fertility was created to address the problem of conflicting, unreliable information about fertility. With patients having to wait up to two years between GP advice and the first outpatient appointment, and no central, official platform for fertility advice, Lucy and Kobi saw the need to support the 1 in 7 couples in the UK that are affected by infertility.
19th June 2019
hero, a health tech and wellbeing strategy provider formed to have a positive influence on individuals, organisations and communities by supporting proactive wellness across all areas of physical, mental and financial health, has closed its latest funding round, raising over £1.3 million to tackle these issues head on.
Having already established itself in the workplace and developer markets and the professional sports sector, hero works with over 100 clients across the UK including names like the NHS, HSBC, Legal and General, Caddick Construction and Inspired Villages. hero has developed and launched a unique digital platform - Navigator to enable employers and organisation to create a full service solution to deliver preventive and personalised experiences for end users.
5th June 2019
Downing Ventures has led a £1.5 million funding in The Electrospinning Company, alongside VC firm MidVen, Newable Private Investing and the STFC.